| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| DissertaĆ§Ć£o | 1.32 MB | Adobe PDF | ||
| Capa | 61.99 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
IntroduĆ§Ć£o: O nĆŗmero de casos detetados tem vindo a aumentar, obrigando a novas exigĆŖncias, tornando necessĆ”rio um investimento tecnolĆ³gico a mĆ©dio prazo. A Prototerapia surge como uma terapĆŖutica emergente para o cancro, prometendo trazer algumas vantagens em relaĆ§Ć£o Ć radioterapia atual. As propriedades fĆsicas do feixe permitem administrar uma maior dose tumoricida salvaguardando os Ć³rgĆ£os de risco, o que possibilita a minimizaĆ§Ć£o dos efeitos secundĆ”rios resultantes da radioterapia. Objetivos: Este trabalho pretende ser um contributo para a radioterapia, relativamente Ć s novas terapĆŖuticas. Como objetivo deste estudo pretende-se conhecer o nĆŗmero de doentes diagnosticados em Portugal com neoplasias pediĆ”tricas, de pulmĆ£o, de prĆ³stata, de mama, de sistema nervoso central, de cabeƧa e pescoƧo, sarcomas e melanomas intraoculares. Material e MĆ©todos: Este trabalho apresenta um estudo descritivo exploratĆ³rio simples quantitativo do tipo transversal. Identificar o nĆŗmero de doentes oncolĆ³gicos diagnosticados em Portugal desde 2006 a 2010, baseados na DireĆ§Ć£o Geral da SaĆŗde, nos quais o nĆŗmero de doentes corresponde aos internados nos hospitais pĆŗblicos em Portugal Continental. As neoplasias escolhidas sĆ£o melanoma intraocular, neoplasias pediĆ”tricas, de prĆ³stata, de cabeƧa e pescoƧo, de mama, de pulmĆ£o e sarcomas. Os dados fornecidos pela DireĆ§Ć£o Geral da SaĆŗde foram analisados por meio do Microsoft Excel do Microsoft Office 2010 do sistema operativo Microsoft Windows XP. A estimativa dos doentes direcionados para prototerapia em Portugal foi baseado num estudo semelhante ao realizado pela Holanda. Resultados e DiscussĆ£o de Resultados: Os resultados apresentados revelam que em 2010 foram diagnosticados 18013 casos em internamento correspondentes Ć s neoplasias em estudo. Consoante a neoplasia diagnosticada e sobre o nĆŗmero total dos casos registados para 2010, podem ser encaminhados, em mĆ©dia, para prototerapia cerca de 25% dos doentes. A estimativa revela que poderiam ser elegĆveis 3789 doentes/ano para prototerapia em Portugal. ConsideraƧƵes Finais: Conclui-se que para Ć instalaĆ§Ć£o de um serviƧo de prototerapia deve-se considerar tratar cerca de 960 doentes/ano. Segundo os resultados obtidos, o valor revelou que poderĆ£o existir doentes suficientes em Portugal para que se justifique a instalaĆ§Ć£o de um serviƧo de prototerapia. Dada a atual conjuntura econĆ³mica, um investimento desta magnitude seria impensĆ”vel, mas dadas as justificaƧƵes fundamentadas relativamente a esta terapĆŖutica oncolĆ³gica, torna-se importante investir nesta Ć”rea.
ABSTRACT - Introduction: The number of cases detected has increased, forcing new requirements, making it necessary technology investment over the medium term. The proton therapy emerges as an emerging therapy for cancer, promising to bring some advantages over current radiotherapy. The physical properties of the beam allows administering a tumoricidal dose greater risk preserving organs, enabling the minimization of side effects resulting from radiotherapy. Objectives: This paper aims to be a contribution to the radiation, for new therapies. Aim of this study is to know the number of patients diagnosed in Portugal with pediatric malignancies, lung, prostate, breast, central nervous system, head and neck, intraocular melanomas and sarcomas. Material and Methods: This paper presents a simple descriptive exploratory study of the transversal type. Identify the number of cancer patients diagnosed in Portugal from 2006 to 2010, based on the General Directorate of Health, in which the number of patients admitted in hospitals corresponds to the public in Portugal. The cases are chosen intraocular melanoma, pediatric malignancies, prostate, head and neck, breast, lung, and sarcomas. The data provided by the Directorate General of Health were analyzed using Microsoft Excel Microsoft Office 2010 Microsoft Windows XP operating system. The estimation of patients directed to proton therapy in Portugal was based on a similar study conducted in Holland. Results and Discussion of Results: The results presented show that in 2010 18,013 cases were diagnosed in inpatient corresponding to the oncology cases under study. Depending on the malignancy diagnosed and the total number of cases reported in 2010, can be routed on average proton therapy to about 25% of patients. The estimate shows that could be eligible to 3789 numbers patients / year to proton therapy in Portugal. Final Thoughts: It is concluded that for the installation of a service proton therapy should consider treating about 960 patients / year. According to the results, the value revealed that there may be patient enough in Portugal to justify the installation of a service proton therapy. Given the current economic climate, an investment of this magnitude would be unthinkable, but given the justifications based on this cancer therapy, it is important to invest in this area.
ABSTRACT - Introduction: The number of cases detected has increased, forcing new requirements, making it necessary technology investment over the medium term. The proton therapy emerges as an emerging therapy for cancer, promising to bring some advantages over current radiotherapy. The physical properties of the beam allows administering a tumoricidal dose greater risk preserving organs, enabling the minimization of side effects resulting from radiotherapy. Objectives: This paper aims to be a contribution to the radiation, for new therapies. Aim of this study is to know the number of patients diagnosed in Portugal with pediatric malignancies, lung, prostate, breast, central nervous system, head and neck, intraocular melanomas and sarcomas. Material and Methods: This paper presents a simple descriptive exploratory study of the transversal type. Identify the number of cancer patients diagnosed in Portugal from 2006 to 2010, based on the General Directorate of Health, in which the number of patients admitted in hospitals corresponds to the public in Portugal. The cases are chosen intraocular melanoma, pediatric malignancies, prostate, head and neck, breast, lung, and sarcomas. The data provided by the Directorate General of Health were analyzed using Microsoft Excel Microsoft Office 2010 Microsoft Windows XP operating system. The estimation of patients directed to proton therapy in Portugal was based on a similar study conducted in Holland. Results and Discussion of Results: The results presented show that in 2010 18,013 cases were diagnosed in inpatient corresponding to the oncology cases under study. Depending on the malignancy diagnosed and the total number of cases reported in 2010, can be routed on average proton therapy to about 25% of patients. The estimate shows that could be eligible to 3789 numbers patients / year to proton therapy in Portugal. Final Thoughts: It is concluded that for the installation of a service proton therapy should consider treating about 960 patients / year. According to the results, the value revealed that there may be patient enough in Portugal to justify the installation of a service proton therapy. Given the current economic climate, an investment of this magnitude would be unthinkable, but given the justifications based on this cancer therapy, it is important to invest in this area.
Description
Mestrado em Radioterapia - Ćrea de especializaĆ§Ć£o: Dosimetria ClĆnica
Keywords
Radioterapia Prototerapia Oncologia Custos na saĆŗde Portugal Radiotherapy Proton therapy Oncology Health investment
Citation
LanƧa C. A implementaĆ§Ć£o de prototerapia no contexto da radioterapia em Portugal [Dissertation]. Lisboa: Escola Superior de Tecnologia da SaĆŗde de Lisboa/Instituto PolitĆ©cnico de Lisboa; 2013.
Publisher
Escola Superior de Tecnologia da SaĆŗde de Lisboa